Yanhong Wang Selected Research

Breast Neoplasms (Breast Cancer)

1/2022	Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?
4/2021	Dosimetric effects of supine immobilization devices on the skin in intensity-modulated radiation therapy for breast cancer: a retrospective study.
1/2021	Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights.
1/2021	Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis.
1/2021	Hyaluronidase and pH Dual-Responsive Nanoparticles for Targeted Breast Cancer Stem Cells.
1/2021	Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms.
11/2020	Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis.
1/2017	Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanhong Wang Research Topics

Disease

28	Neoplasms (Cancer) 06/2022 - 09/2002
12	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2009
12	Fibrosis (Cirrhosis) 11/2021 - 10/2004
10	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2015
8	Inflammation (Inflammations) 01/2022 - 08/2014
8	Schizophrenia (Dementia Praecox) 01/2022 - 08/2007
8	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
7	Cognitive Dysfunction 01/2022 - 08/2010
7	Infections 01/2022 - 11/2014
6	Liver Neoplasms (Liver Cancer) 09/2018 - 08/2011
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 03/2016
4	Nervous System Diseases (Neurological Disorders) 04/2022 - 01/2017
4	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 08/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2016
4	Carcinogenesis 01/2022 - 08/2016
4	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2021
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2021 - 12/2017
4	Hemorrhage 01/2021 - 03/2013
4	Virus Diseases (Viral Diseases) 12/2019 - 12/2014
3	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2022 - 01/2021
3	Memory Disorders (Memory Loss) 02/2022 - 08/2020
3	Hypertension (High Blood Pressure) 01/2022 - 01/2016
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2019
3	IGA Glomerulonephritis (IGA Nephropathy) 12/2015 - 01/2014
3	Proteinuria 12/2015 - 01/2014
3	Leukemia 01/2009 - 10/2004
2	Arteriosclerosis 06/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2021
2	Frailty 05/2022 - 10/2020
2	Atherosclerosis 03/2022 - 06/2011
2	Axial Spondyloarthritis 03/2022 - 01/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2021
2	Sepsis (Septicemia) 01/2022 - 12/2014
2	Hyperglycemia 01/2022 - 01/2021
2	Hyperplasia 01/2022 - 01/2018
2	Critical Illness (Critically Ill) 01/2022 - 01/2022
2	Obesity 01/2022 - 08/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021 - 08/2014
2	Pathologic Processes 10/2021 - 01/2020
2	Necrosis 04/2021 - 10/2004
2	Lupus Nephritis 10/2020 - 01/2020
2	Kidney Diseases (Kidney Disease) 10/2020 - 10/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 10/2004
2	Lung Neoplasms (Lung Cancer) 01/2020 - 10/2019

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2006
7	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2014
7	Protein Isoforms (Isoforms)IBA 01/2021 - 08/2007
6	Pharmaceutical PreparationsIBA 01/2022 - 10/2004
6	CateninsIBA 12/2021 - 01/2015
5	CytokinesIBA 01/2022 - 12/2014
5	Biological ProductsIBA 01/2020 - 07/2012
5	LipopolysaccharidesIBA 09/2016 - 12/2014
4	LipidsIBA 06/2022 - 06/2011
4	Indicators and Reagents (Reagents)IBA 05/2022 - 01/2016
4	AluminumIBA 02/2022 - 08/2020
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2017
4	AlbuminsIBA 01/2022 - 09/2014
4	CreatinineIBA 01/2020 - 10/2016
4	Neuregulin-1 (Neuregulin 1)IBA 01/2016 - 08/2007
3	Apolipoproteins E (ApoE)IBA 03/2022 - 06/2011
3	AntioxidantsIBA 01/2021 - 11/2015
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2015
3	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2014
3	Sorafenib (BAY 43-9006)FDA Link 09/2018 - 08/2009
3	CollagenIBA 07/2017 - 01/2004
3	NeuregulinsIBA 01/2017 - 08/2010
3	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 09/2014
3	Poly I-CIBA 09/2016 - 12/2014
3	Immunoglobulin A (IgA)IBA 12/2015 - 01/2014
3	NucleosidesIBA 08/2008 - 08/2002
2	Polysaccharides (Glycans)IBA 06/2022 - 01/2020
2	oxidized low density lipoproteinIBA 06/2022 - 03/2022
2	Dronabinol (THC)FDA LinkGeneric 04/2022 - 03/2022
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 03/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2010
2	Autophagy-Related ProteinsIBA 01/2022 - 04/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2017
2	HDL LipoproteinsIBA 01/2022 - 04/2021
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 04/2021
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 11/2020
2	C-Reactive ProteinIBA 01/2022 - 10/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 10/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021 - 10/2020
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 08/2017
2	Saline SolutionIBA 04/2021 - 03/2013
2	Retinaldehyde (Retinal)IBA 01/2021 - 12/2018
2	BilirubinIBA 01/2021 - 01/2019
2	Estrogens (Estrogen)FDA Link 10/2020 - 10/2019
2	Dihydrotachysterol (AT 10)IBA 01/2020 - 11/2003
2	SodiumIBA 01/2020 - 01/2016
2	Sitagliptin Phosphate (Januvia)FDA Link 11/2019 - 01/2017

Therapy/Procedure

11	Therapeutics 06/2022 - 08/2011
5	Radiotherapy 01/2022 - 10/2019
4	Radiofrequency Ablation 12/2016 - 08/2011
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 06/2021
2	Hysterectomy 04/2021 - 10/2020
2	Adjuvant Chemotherapy 01/2021 - 10/2019